Ulipristal-Acetate API Manufacturers

compare suppliers & get competitive offers



Selected filters:

Production region
Country of origin


Produced in:


Established in: 2005

MOQ: -

Employees: 200+

Portfolio of over 2,000 APIs

Precise quality control

End-to-end global regulatory support

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CEP

  • GMP

  • CoA

  • MSDS


Contact supplier

Replies quickly

How does it work?

Register for free

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

Start sourcing

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

Send inquiries

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

Get quotation

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

Arrange agreement

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Ulipristal-Acetate API 126784-99-4?

Here you will find a list of producers, manufacturers and traders of Ulipristal-Acetate. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Cas Number:
DrugBank number:
Unique Ingredient Identifier:

Ulipristal-Acetate is a type of Contraceptives

Contraceptives are a vital subcategory within the pharmaceutical active pharmaceutical ingredient (API) sector. These substances play a crucial role in preventing unwanted pregnancies and providing individuals with reliable birth control options. Contraceptives are designed to interfere with the natural processes of fertilization and implantation, thereby reducing the chances of conception.

APIs used in contraceptives exhibit specific mechanisms of action to ensure effective contraception. These may include inhibiting ovulation, altering cervical mucus consistency, or impeding sperm mobility and viability. By utilizing targeted APIs, contraceptive manufacturers can develop diverse products, including oral contraceptive pills, contraceptive patches, intrauterine devices (IUDs), and contraceptive injections.

The pharmaceutical industry places utmost importance on the quality, safety, and efficacy of contraceptive APIs. Stringent regulations govern their production, ensuring adherence to Good Manufacturing Practices (GMP) and quality control standards. Additionally, pharmaceutical companies invest in comprehensive research and development to enhance contraceptive formulations, minimize side effects, and improve user compliance.

Contraceptives are widely utilized across the globe, offering individuals the ability to make informed choices regarding family planning and reproductive health. With increasing awareness and evolving societal norms, the demand for effective contraceptives continues to grow. Pharmaceutical API manufacturers play a pivotal role in meeting this demand by producing high-quality contraceptive APIs that provide reliable and accessible birth control options to individuals worldwide.

Ulipristal-Acetate (Contraceptives), classified under Genitourinary Agents

Genitourinary agents are a category of pharmaceutical active ingredients (APIs) that are specifically designed to target and treat disorders related to the genitourinary system. The genitourinary system encompasses the organs and structures involved in the production, storage, and elimination of urine, as well as the reproductive organs.

These APIs play a crucial role in the treatment of various genitourinary conditions, including urinary tract infections (UTIs), erectile dysfunction, urinary incontinence, benign prostatic hyperplasia (BPH), and other related disorders. They exert their therapeutic effects by interacting with specific receptors or enzymes in the genitourinary system, regulating physiological processes, and restoring normal function.

Some commonly used genitourinary agents include alpha-blockers, which relax the smooth muscles in the prostate and bladder neck, improving urine flow in patients with BPH. Additionally, phosphodiesterase type 5 inhibitors (PDE5 inhibitors) are widely prescribed for erectile dysfunction, as they enhance blood flow to the penile tissues, facilitating erection.

These APIs are typically formulated into various dosage forms, such as tablets, capsules, creams, gels, or injections, allowing for convenient administration to patients. The development and production of genitourinary agents involve stringent quality control measures and compliance with regulatory guidelines to ensure safety, efficacy, and consistent product performance.

In summary, genitourinary agents form a crucial category of pharmaceutical APIs used to treat a range of disorders affecting the genitourinary system. Their targeted mechanisms of action and diverse dosage forms make them valuable tools in improving genitourinary health and enhancing patients' quality of life.

Ulipristal-Acetate manufacturers | traders | suppliers

We have 1 companies offering Ulipristal-Acetate produced in 1 different countries.

Get in contact with the supplier of your choice:

  • LGM Pharma from United States, product country of origin World

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.